Skip to main content
Premium Trial:

Request an Annual Quote

HGS Shares Rise After Stock Split Approved

NEW YORK, Sept 19 - Human Genome Sciences (Nasdaq: HGSI) stock jumped 9 13/16, or 6.8 percent, to 153 13/16 in mid-morning trading Tuesday following an announcement on  Monday after the close of trading that the company’s board had approved a two-for-one stock split.

Shareholders will receive an additional common share for each share held at close-of-business on Sept. 28. The additional shares will be delivered on or about Oct. 5.

After the completion of the split HGS will have 56 million shares outstanding.

This is the second split of HGS common stock since the company’s IPO in December of 1993.

HGS's shares reached a 52-week high of 232 3/4 in early March.

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.